T. Kuş Et Al. , "Benefits and Toxicity of Taxane Addition to Platinum-Fluoropyrimidine Combination in Gastric Cancer Patients with Peritoneal Metastasis," Journal of Oncological Science , vol.8, no.3, pp.127-134, 2022
Kuş, T. Et Al. 2022. Benefits and Toxicity of Taxane Addition to Platinum-Fluoropyrimidine Combination in Gastric Cancer Patients with Peritoneal Metastasis. Journal of Oncological Science , vol.8, no.3 , 127-134.
Kuş, T., Yildirim Özdemir, N., Aktaş, G., SÜTCÜOĞLU, O., Yalçintaş Arslan, Ü., Dirikoç, M., ... Köse, F.(2022). Benefits and Toxicity of Taxane Addition to Platinum-Fluoropyrimidine Combination in Gastric Cancer Patients with Peritoneal Metastasis. Journal of Oncological Science , vol.8, no.3, 127-134.
Kuş, Tülay Et Al. "Benefits and Toxicity of Taxane Addition to Platinum-Fluoropyrimidine Combination in Gastric Cancer Patients with Peritoneal Metastasis," Journal of Oncological Science , vol.8, no.3, 127-134, 2022
Kuş, Tülay Et Al. "Benefits and Toxicity of Taxane Addition to Platinum-Fluoropyrimidine Combination in Gastric Cancer Patients with Peritoneal Metastasis." Journal of Oncological Science , vol.8, no.3, pp.127-134, 2022
Kuş, T. Et Al. (2022) . "Benefits and Toxicity of Taxane Addition to Platinum-Fluoropyrimidine Combination in Gastric Cancer Patients with Peritoneal Metastasis." Journal of Oncological Science , vol.8, no.3, pp.127-134.
@article{article, author={Tülay Kuş Et Al. }, title={Benefits and Toxicity of Taxane Addition to Platinum-Fluoropyrimidine Combination in Gastric Cancer Patients with Peritoneal Metastasis}, journal={Journal of Oncological Science}, year=2022, pages={127-134} }